These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 17988876

  • 1. Discovery of new MurF inhibitors via pharmacophore modeling and QSAR analysis followed by in-silico screening.
    Taha MO, Atallah N, Al-Bakri AG, Paradis-Bleau C, Zalloum H, Younis KS, Levesque RC.
    Bioorg Med Chem; 2008 Feb 01; 16(3):1218-35. PubMed ID: 17988876
    [Abstract] [Full Text] [Related]

  • 2. Discovery of DPP IV inhibitors by pharmacophore modeling and QSAR analysis followed by in silico screening.
    Al-Masri IM, Mohammad MK, Taha MO.
    ChemMedChem; 2008 Nov 01; 3(11):1763-79. PubMed ID: 18989859
    [Abstract] [Full Text] [Related]

  • 3. Combining ligand-based pharmacophore modeling, quantitative structure-activity relationship analysis and in silico screening for the discovery of new potent hormone sensitive lipase inhibitors.
    Taha MO, Dahabiyeh LA, Bustanji Y, Zalloum H, Saleh S.
    J Med Chem; 2008 Oct 23; 51(20):6478-94. PubMed ID: 18808096
    [Abstract] [Full Text] [Related]

  • 4. Pharmacophore and QSAR modeling of estrogen receptor beta ligands and subsequent validation and in silico search for new hits.
    Taha MO, Tarairah M, Zalloum H, Abu-Sheikha G.
    J Mol Graph Model; 2010 Jan 23; 28(5):383-400. PubMed ID: 19850503
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Discovery of new renin inhibitory leads via sequential pharmacophore modeling, QSAR analysis, in silico screening and in vitro evaluation.
    Al-Nadaf AH, Taha MO.
    J Mol Graph Model; 2011 Apr 23; 29(6):843-64. PubMed ID: 21376648
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Elaborate ligand-based modeling reveals new nanomolar heat shock protein 90α inhibitors.
    Al-Sha'er MA, Taha MO.
    J Chem Inf Model; 2010 Sep 27; 50(9):1706-23. PubMed ID: 20831219
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Elaborate ligand-based pharmacophore exploration and QSAR analysis guide the synthesis of novel pyridinium-based potent beta-secretase inhibitory leads.
    Al-Nadaf A, Abu Sheikha G, Taha MO.
    Bioorg Med Chem; 2010 May 01; 18(9):3088-115. PubMed ID: 20378363
    [Abstract] [Full Text] [Related]

  • 14. Ligand-based assessment of factor Xa binding site flexibility via elaborate pharmacophore exploration and genetic algorithm-based QSAR modeling.
    Taha MO, Qandil AM, Zaki DD, AlDamen MA.
    Eur J Med Chem; 2005 Jul 01; 40(7):701-27. PubMed ID: 15935905
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.